MF

Meredith Fisher

Partner, Mass General Brigham Ventures

Cambridge, Massachusetts

Invests in

Stages:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • Co-founding CEO and Director

    2022

  • Partner, Mass General Brigham Ventures

    2016

    Mass General Brigham Ventures is an early-stage venture capital firm founded in 2008 to advance new science and technology based on discovery and invention originating from Mass General Brigham. The fund invests in medical innovations created by MGB’s world-class research hospitals. We invest in leading-edge life science technologies with the goal of bringing discoveries, inventions and innovations from MGB to market for the benefit of patients worldwide. Portfolio: FireCyte, Violet, Nocion, Mediar, Amolyt Pharma, ZielBio, Scorpion and Claris Bio

2019 - 2023

  • Co-founding CEO and Director

    2019 - 2023

  • Director, Private Investments

    2013 - 2015

2012 - 2013

  • Head, Business Development

    2012 - 2013

    Ginkgo Bioworks designs custom microbes for customers across multiple markets, developing new organisms that replace technology with biology. www.ginkgobioworks.com

  • Senior Director of Technology & Business Development at Enlight Biosciences

    2009 - 2012

    Enlight is a venture creation firm founded by PureTech Ventures.

  • Associate Scientist

    2001 - 2002

  • Associate Scientist

    1998 - 2000